SPECIFIC PLASMINOGEN-ACTIVATOR INHIBITOR OF PLACENTAL TYPE PAI-2 OCCURRING IN AMNIOTIC-FLUID AND CORD BLOOD

被引：0
|
作者：
LECANDER, I [1 ]
ASTEDT, B [1 ]
机构：
[1] UNIV LUND HOSP,DEPT GYNAECOL & OBSTET,RES LAB,KVINNOKLINIKEN I LUND,S-22185 LUND,SWEDEN
来源：
JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 1987年 / 110卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：602 / 605
页数：4
相关论文
共 50 条
  • [1] EPIDERMAL PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) IS IMMUNOLOGICALLY IDENTICAL TO PLACENTAL-TYPE PAI-2
    HIBINO, T
    IZAKI, S
    OHKUMA, M
    KON, S
    THORSEN, S
    ASTEDT, B
    FEBS LETTERS, 1988, 231 (01) : 202 - 206
  • [2] IDENTITY BETWEEN THE PLACENTAL PROTEIN PP10 AND THE SPECIFIC PLASMINOGEN-ACTIVATOR INHIBITOR OF PLACENTAL TYPE PAI-2
    KISO, U
    HENSCHEN, A
    BOHN, H
    HEIMBURGER, N
    RADTKE, KP
    LECANDER, I
    ASTEDT, B
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1074 (01) : 74 - 78
  • [3] OCCURRENCE OF A SPECIFIC PLASMINOGEN-ACTIVATOR INHIBITOR OF PLACENTAL TYPE, PAI-2, IN MEN AND NON-PREGNANT WOMEN
    LECANDER, I
    ASTEDT, B
    FIBRINOLYSIS, 1989, 3 (01) : 27 - 30
  • [4] OCCURRENCE OF THE SPECIFIC PLASMINOGEN-ACTIVATOR INHIBITOR OF PLACENTAL TYPE, PAI-2 IN ASCITIC FLUID AND TUMOR VESSEL BLOOD FROM PATIENTS WITH OVARIAN-CARCINOMA
    LECANDER, I
    MARTINSSON, G
    CASSLEN, B
    ANDREASEN, PA
    ASTEDT, B
    FIBRINOLYSIS, 1990, 4 (04) : 221 - 224
  • [5] Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy
    Åstedt, B
    Lindoff, C
    Lecander, I
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1998, 24 (05): : 431 - 435
  • [6] A PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-2) IN OVARIAN CYSTS
    REITH, A
    BOOTH, NA
    BENNETT, B
    BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (01) : 133 - 133
  • [7] EFFECT OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) ON NEOVASCULARIZATION
    WILIAMS, GA
    CHAPMAN, C
    CHENG, M
    SHETTLE, L
    OMALLEY, B
    TRESE, M
    HARTZER, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1080 - 1080
  • [8] IS PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 (PAI-2) SECRETED IN A TISSUE-SPECIFIC MANNER
    MIKUS, P
    LILJESTROM, P
    NY, T
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1329 - 1329
  • [9] THE PLASMINOGEN-ACTIVATOR UROKINASE AND ITS INHIBITOR PAI-2 IN ENDOMETRIAL CANCER
    GLEESON, N
    GONSALVES, R
    BONNAR, J
    GYNECOLOGIC ONCOLOGY, 1992, 47 (01) : 58 - 61
  • [10] THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION
    HIBINO, T
    OONUMA, M
    TAKAHASHI, T
    HORII, I
    CLINICAL RESEARCH, 1992, 40 (02): : A514 - A514
12345